Βιολογική αξιολόγηση προϊόντων για ιατρική χρήση - Μέρος 3: Δοκιμές για γενοτοξικότητα, ικανότητα καρκινογένεσης και αναπαραγωγική τοξικότητα

ISO 10993-3:2014 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices: genotoxicity; carcinogenicity; reproductive and developmental toxicity. ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.